BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30095702)

  • 1. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
    Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
    Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study.
    Kong TW; Lee JD; Son JH; Paek J; Chun M; Chang SJ; Ryu HS
    Gynecol Oncol; 2016 Oct; 143(1):77-82. PubMed ID: 27423377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
    Mabuchi S; Okazawa M; Isohashi F; Matsuo K; Ohta Y; Suzuki O; Yoshioka Y; Enomoto T; Kamiura S; Kimura T
    Gynecol Oncol; 2011 Nov; 123(2):241-7. PubMed ID: 21820708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
    Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
    BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.
    Liu P; Lin L; Kong Y; Huo Z; Zhu L; Bin X; Lang J; Chen C
    BMC Cancer; 2020 Mar; 20(1):189. PubMed ID: 32138718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
    Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
    Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.
    Derks M; Groenman FA; van Lonkhuijzen LRCW; Schut PC; Westerveld H; van der Velden J; Kenter GG
    Int J Gynecol Cancer; 2017 Jun; 27(5):1015-1020. PubMed ID: 28498252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer.
    Soochit A; Zhang C; Feng Y; Luo X; Huang H; Liu J
    Int J Gynecol Cancer; 2023 Jun; 33(6):882-889. PubMed ID: 37001894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study.
    Chen B; Ji M; Li P; Liu P; Zou W; Zhao Z; Qu B; Li Z; Bin X; Lang J; Wang H; Chen C
    Gynecol Oncol; 2020 May; 157(2):429-436. PubMed ID: 32067814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
    Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
    Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.
    Albert A; Allbright R; Lee A; Vijayakumar S
    J Gynecol Oncol; 2019 May; 30(3):e41. PubMed ID: 30887759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of bulky pTIIB cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
    Okadome M; Nagayama R; Shimokawa M; Sonoda K; Shimamoto K; Saito T
    Int J Gynaecol Obstet; 2021 Apr; 153(1):56-63. PubMed ID: 33119174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
    van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
    Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefits with the addition of adjuvant hysterectomy to radiochemotherapy for treatment of stage I-II adenocarcinoma of the uterine cervix.
    Huang XB; Zhang WW; Wu SG; Sun JY; He ZY; Zhou J
    J Surg Oncol; 2018 Sep; 118(3):574-580. PubMed ID: 30114328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.